The SP has appreciated 902% in the last 12 months. I'd say the...

The SP has appreciated 902% in the last 12 months. I'd say the market is pretty convinced about the demand for Relenza! Production has been increased. Royalties are flowing in, company is paying dividends. Where's the problem? Are you saying the SP should be $10 by now and it's not because of Peter Cook & GSK?

I think we all know BTA is currently undervalued even at $3.41. IMO, I'd rather see slow and steady increases in SP rather than a sudden re-rating. As for Peter Cook talking down the Relenza prospects, well at least he's not blatantly upramping the company and it's potential like some CEO's do.